North America dominates the Structural and Filling Bone Grafts market with a 45% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. The regionโs aging population and rising orthopedic trauma cases further fuel demand. Europe follows with 30%, supported by favorable reimbursement policies, a mature medical device ecosystem, and strong regulatory frameworks promoting regenerative therapies. Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 12% through 2030, fueled by rising disposable incomes, urbanization-driven healthcare access, and demographic shifts increasing spinal and dental procedures. Latin America and the Middle East & Africa collectively contribute 15% and 10%, respectively, with growth spurred by public-private partnerships enhancing surgical infrastructure and increasing partnerships with global manufacturers.